Could a promising cancer drug cure atherosclerosis?
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000209:etiology; D003094:Collagen / Q000627:therapeutic use; D003510:Cyclohexanes; D043169:Endostatins; D006801:Humans; D051379:Mice; D000077609:O-(Chloroacetylcarbamoyl)fumagillol; D010446:Peptide Fragments / Q000627:therapeutic use; D012717:Sesquiterpenes / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D003510:Cyclohexanes; D043169:Endostatins; D010446:Peptide Fragments; D012717:Sesquiterpenes; D003094:Collagen; D000077609:O-(Chloroacetylcarbamoyl)fumagillol